1 |
Chenari A, Hazrati A, Hosseini AZ, Motiee M, Soudi S. The effect of mesenchymal stem cell-derived supernatant nasal administration on lung inflammation and immune response in BCG-vaccinated BALB/c mice. Life Sci 2023;317:121465. [PMID: 36731650 DOI: 10.1016/j.lfs.2023.121465] [Reference Citation Analysis]
|
2 |
Hashemi B, Abdollahi M, Abbaspour-Aghdam S, Hazrati A, Malekpour K, Meshgi S, Kafil HS, Ghazi F, Yousefi M, Roshangar L, Ahmadi M. The effect of probiotics on immune responses and their therapeutic application: A new treatment option for multiple sclerosis. Biomed Pharmacother 2023;159:114195. [PMID: 36630847 DOI: 10.1016/j.biopha.2022.114195] [Reference Citation Analysis]
|
3 |
Malekpour K, Hazrati A, Soudi S, Hashemi SM. Mechanisms behind therapeutic potentials of mesenchymal stem cell mitochondria transfer/delivery. J Control Release 2023;354:755-69. [PMID: 36706838 DOI: 10.1016/j.jconrel.2023.01.059] [Reference Citation Analysis]
|
4 |
Isaković J, Šerer K, Barišić B, Mitrečić D. Mesenchymal stem cell therapy for neurological disorders: The light or the dark side of the force? Front Bioeng Biotechnol 2023;11:1139359. [PMID: 36926687 DOI: 10.3389/fbioe.2023.1139359] [Reference Citation Analysis]
|
5 |
Hazrati A, Malekpour K, Soudi S, Hashemi SM. CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations. Biomedicine & Pharmacotherapy 2022;156:113943. [DOI: 10.1016/j.biopha.2022.113943] [Reference Citation Analysis]
|
6 |
Dolgacheva LP, Zinchenko VP, Goncharov NV. Molecular and Cellular Interactions in Pathogenesis of Sporadic Parkinson Disease. IJMS 2022;23:13043. [DOI: 10.3390/ijms232113043] [Reference Citation Analysis]
|